▶
2025-07-08
64 other
⚡ 11 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| LAI GOLDMAN MYLA | — | J | 20,000 | — | — | Jul 10 | |
| LAI GOLDMAN MYLA | — | J | 38,993 | $0 | $0 | Jul 10 | |
| LAI GOLDMAN MYLA | — | J | 30,549 | $0 | $0 | Jul 10 | |
| LAI GOLDMAN MYLA | — | J | 56,322 | $0 | $0 | Jul 10 | |
| LAI GOLDMAN MYLA | — | J | 50,000 | $0 | $0 | Jul 10 | |
| Raffin Thomas A. | — | J | 234,592 | — | — | Jul 10 | |
| Raffin Thomas A. | — | J | 1,737,712 | — | — | Jul 10 | |
| Raffin Thomas A. | — | J | 15,937,535 | — | — | Jul 10 | |
| Raffin Thomas A. | — | J | 16,860 | $0 | $0 | Jul 10 | |
| Raffin Thomas A. | — | J | 30,549 | $0 | $0 | Jul 10 | |
| Raffin Thomas A. | — | J | 56,322 | $0 | $0 | Jul 10 | |
| Raffin Thomas A. | — | J | 50,000 | $0 | $0 | Jul 10 | |
| SCHNETTLER THOMAS P | — | J | 16,860 | $0 | $0 | Jul 10 | |
| SCHNETTLER THOMAS P | — | J | 30,549 | $0 | $0 | Jul 10 | |
| SCHNETTLER THOMAS P | — | J | 56,322 | $0 | $0 | Jul 10 | |
| SCHNETTLER THOMAS P | — | J | 50,000 | $0 | $0 | Jul 10 | |
| SHEPLER ROBERT G | — | J | 16,860 | $0 | $0 | Jul 10 | |
| SHEPLER ROBERT G | — | J | 30,549 | $0 | $0 | Jul 10 | |
| SHEPLER ROBERT G | — | J | 56,322 | $0 | $0 | Jul 10 | |
| SHEPLER ROBERT G | — | J | 50,000 | $0 | $0 | Jul 10 | |
| Winkler Matthew | — | J | 984,513 | — | — | Jul 10 | |
| Winkler Matthew | — | J | 16,860 | $0 | $0 | Jul 10 | |
| Winkler Matthew | — | J | 30,549 | $0 | $0 | Jul 10 | |
| Winkler Matthew | — | J | 56,322 | $0 | $0 | Jul 10 | |
| Winkler Matthew | — | J | 50,000 | $0 | $0 | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 9,488 | — | — | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 196,250 | — | — | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 150,000 | $0 | $0 | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 25,000 | $0 | $0 | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 15,000 | $0 | $0 | Jul 10 | |
| BAMFORD PASCAL | Chief Clinical Officer | J | 50,000 | $0 | $0 | Jul 10 | |
| Ek John Frederick | CFO | J | 54,452 | — | — | Jul 10 | |
| Ek John Frederick | CFO | J | 193,750 | — | — | Jul 10 | |
| Ek John Frederick | CFO | J | 20,000 | — | — | Jul 10 | |
| Ek John Frederick | CFO | J | 160,000 | $0 | $0 | Jul 10 | |
| Ek John Frederick | CFO | J | 70,000 | $0 | $0 | Jul 10 | |
| Kamocsay Jennifer | Chief Legal Officer | J | 16,772 | — | — | Jul 10 | |
| Kamocsay Jennifer | Chief Legal Officer | J | 162,500 | — | — | Jul 10 | |
| Kamocsay Jennifer | Chief Legal Officer | J | 75,000 | $0 | $0 | Jul 10 | |
| Kamocsay Jennifer | Chief Legal Officer | J | 70,000 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 393,338 | — | — | Jul 10 | |
| McKelligon Brian | President and CEO | J | 331,090 | — | — | Jul 10 | |
| McKelligon Brian | President and CEO | F | 196,866 | — | — | Jul 10 | |
| McKelligon Brian | President and CEO | J | 947,688 | — | — | Jul 10 | |
| McKelligon Brian | President and CEO | J | 393,338 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 331,090 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 241,592 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 160,000 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 160,000 | $0 | $0 | Jul 10 | |
| McKelligon Brian | President and CEO | J | 175,000 | $0 | $0 | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 62,566 | — | — | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | F | 42,148 | — | — | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 151,930 | — | — | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 130,625 | — | — | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 62,566 | $0 | $0 | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 45,000 | $0 | $0 | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 45,000 | $0 | $0 | Jul 10 | |
| Ramachandran Niro Ph.D | Chief Business Officer | J | 70,000 | $0 | $0 | Jul 10 | |
| Mendel Scott | — | J | 28,500 | — | — | Jul 10 | |
| Mendel Scott | — | J | 35,562 | $0 | $0 | Jul 10 | |
| Mendel Scott | — | J | 30,549 | $0 | $0 | Jul 10 | |
| Mendel Scott | — | J | 56,322 | $0 | $0 | Jul 10 | |
| Mendel Scott | — | J | 44,959 | $0 | $0 | Jul 10 | |
| Mendel Scott | — | J | 50,000 | $0 | $0 | Jul 10 |
▶
2025-06-01
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| BAMFORD PASCAL | Chief Clinical Officer | F | 670 | $1 | $838 | Jun 2 |